Komori
M&A and Subsidiary Changes4527ROHTO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

(Correction) Notice Regarding the Acquisition of an Equity Interest in Magic Cod d.o.o., a Serbian Cosmetics Distributor, Making It a Subsidiary

The spelling of the representative's name and major shareholder's name stated in the original disclosure has been corrected from the incorrect “Danijela Kovač ević” to the correct “Danijela Kovačević.” The corrections concern 2 items in the subsidiary overview.

Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure9 July 2026 (Thursday)

Notice Concerning the Acquisition of an Equity Interest in Magic Cod d.o.o., a Serbian Cosmetics Distributor, Making It a Subsidiary

Open the original document
Corrected on the same dayCorrected on the same day as the original document (Calculated from the Original Disclosure Date Indicated in the Document)
This correction2026-07-09
Location of correction (where in the original document)

2. Overview of the Subsidiary to Be Changed: (3) Representative's Title and Name; (7) Major Shareholders and Equity Interest Ratio

Before correction

(3)Managing Director - Danijela Kovač ević、(7)Danijela Kovač ević 100%

After correction

(3)Managing Director - Danijela Kovačević、(7)Danijela Kovačević 100%

ChangesThe spelling of the representative's name and major shareholder's name has been corrected from “Danijela Kovač ević” to “Danijela Kovačević.”
Impact on Business Performance (the company’s explanation)

The impact of this matter on consolidated results for the current fiscal year will be immaterial, but we believe it will contribute to enhancing the corporate value of our group over the medium to long term.

Reason for correction

Some errors were contained in the press release distributed at 15:30 on 9 July 2026 (Thursday).

What was corrected and how
ItemDetails
Disclosure subject to correctionNotice Concerning the Acquisition of an Equity Interest in Magic Cod d.o.o., a Serbian Cosmetics Distributor, Making It a Subsidiary
Original disclosure date9 July 2026 (Thursday)
Location of correction2. Overview of the Subsidiary to Be Changed: (3) Representative's Title and Name; (7) Major Shareholders and Equity Interest Ratio
Details of correction(3)Managing Director - Danijela Kovač ević、(7)Danijela Kovač ević 100% → (3)Managing Director - Danijela Kovačević、(7)Danijela Kovačević 100%
Reason for correctionSome errors were contained in the press release distributed at 15:30 on 9 July 2026 (Thursday).
Impact on Business PerformanceThe impact of this matter on consolidated results for the current fiscal year will be immaterial, but we believe it will contribute to enhancing the corporate value of our group over the medium to long term.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the press release distributed at 15:30 on 9 July 2026 contained some errors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
(Correction) Notice Regarding the Acquisition of an Equity Interest in Magic Cod d.o.o., a Serbian Cosmetics Distributor, Making It a Subsidiary | ROHTO PHARMACEUTICAL CO.,LTD. (4527) timely disclosure | Komori